{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:13:33Z","timestamp":1780103613390,"version":"3.54.0"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T00:00:00Z","timestamp":1323820800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0028611","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T20:17:08Z","timestamp":1323893828000},"page":"e28611","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["PEGylation Potentiates the Effectiveness of an Antagonistic Peptide That Targets the EphB4 Receptor with Nanomolar Affinity"],"prefix":"10.1371","volume":"6","author":[{"given":"Roberta","family":"Noberini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayantan","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Salvucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Duggineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Prigozhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Tosato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena B.","family":"Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,12,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond.","volume":"10","author":"EB Pasquale","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1158\/0008-5472.CAN-07-0525","article-title":"Paradoxes of the EphB4 receptor in cancer.","volume":"67","author":"NK Noren","year":"2007","journal-title":"Cancer Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/sj.bjc.6603642","article-title":"The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome.","volume":"96","author":"SR Kumar","year":"2007","journal-title":"Br J Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1158\/0008-5472.CAN-08-3232","article-title":"Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.","volume":"69","author":"SR Kumar","year":"2009","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.onc.1209108","article-title":"EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.","volume":"25","author":"G Xia","year":"2006","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1158\/1078-0432.CCR-04-2109","article-title":"Up-Regulation of EphB4 in Mesothelioma and Its Biological Significance.","volume":"11","author":"G Xia","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nature03626","article-title":"EphB receptor activity suppresses colorectal cancer progression.","volume":"435","author":"E Batlle","year":"2005","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1158\/1541-7786.MCR-09-0453","article-title":"EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinb2.","volume":"8","author":"M Heroult","year":"2010","journal-title":"Mol Cancer Res"},{"key":"ref9","first-page":"1197","article-title":"Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells.","volume":"27","author":"S Meyer","year":"2005","journal-title":"Int J Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"32574","DOI":"10.1074\/jbc.M604338200","article-title":"The EphB4 Receptor-tyrosine Kinase Promotes the Migration of Melanoma Cells through Rho-mediated Actin Cytoskeleton Reorganization.","volume":"281","author":"NY Yang","year":"2006","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1755-148X.2010.00745.x","article-title":"The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand.","volume":"23","author":"NY Yang","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1158\/0008-5472.CAN-09-0706","article-title":"The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.","volume":"69","author":"H Dopeso","year":"2009","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.yexcr.2005.10.028","article-title":"Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression.","volume":"312","author":"M Heroult","year":"2006","journal-title":"Exp Cell Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tcm.2007.03.003","article-title":"Regulation of angiogenesis by Eph-ephrin interactions.","volume":"17","author":"S Kuijper","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1073\/pnas.0401381101","article-title":"Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.","volume":"101","author":"NK Noren","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1242\/jcs.00426","article-title":"Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.","volume":"116","author":"T Fuller","year":"2003","journal-title":"J Cell Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0898-6568(03)00072-X","article-title":"Role of ephrin B2 in human retinal endothelial cell proliferation and migration.","volume":"15","author":"JJ Steinle","year":"2003","journal-title":"Cell Signal"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature08995","article-title":"Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.","volume":"465","author":"S Sawamiphak","year":"2010","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature09002","article-title":"Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.","volume":"465","author":"Y Wang","year":"2010","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2005.10.034","article-title":"Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly.","volume":"124","author":"SS Foo","year":"2006","journal-title":"Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1182\/blood-2008-12-192294","article-title":"EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures.","volume":"114","author":"O Salvucci","year":"2009","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.emboj.7600949","article-title":"EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.","volume":"25","author":"R Erber","year":"2006","journal-title":"Embo J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2353\/ajpath.2010.090755","article-title":"Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth.","volume":"176","author":"V Krasnoperov","year":"2010","journal-title":"Am J Pathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10456-010-9183-z","article-title":"The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.","volume":"13","author":"G Martiny-Baron","year":"2010","journal-title":"Angiogenesis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cmet.2006.05.012","article-title":"Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.","volume":"4","author":"C Zhao","year":"2006","journal-title":"Cell Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jcb.22680","article-title":"Endothelial cells regulate cardiomyocyte development from embryonic stem cells.","volume":"111","author":"K Chen","year":"2010","journal-title":"J Cell Biochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2003-04-1063","article-title":"Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels.","volume":"103","author":"Z Wang","year":"2004","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1593\/neo.03457","article-title":"Inhibition of tumor growth and angiogenesis by soluble EphB4.","volume":"6","author":"G Martiny-Baron","year":"2004","journal-title":"Neoplasia"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1182\/blood-2005-04-1655","article-title":"The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.","volume":"107","author":"N Kertesz","year":"2006","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1186\/1471-2407-10-641","article-title":"Combination of Dll4\/Notch and Ephrin-B2\/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.","volume":"10","author":"D Djokovic","year":"2010","journal-title":"BMC Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1182\/blood-2008-02-140020","article-title":"The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.","volume":"113","author":"JS Scehnet","year":"2009","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1755-3768.2009.01609.x","article-title":"Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.","volume":"89","author":"C Ehlken","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"17301","DOI":"10.1074\/jbc.M500363200","article-title":"EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.","volume":"280","author":"M Koolpe","year":"2005","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.110.081943","article-title":"In vivo small-animal PET\/CT of EphB4 receptors using 64Cu-labeled peptide.","volume":"52","author":"C Xiong","year":"2011","journal-title":"J Nucl Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.str.2005.11.011","article-title":"Structure and thermodynamic characterization of the EphB4\/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity.","volume":"14","author":"JE Chrencik","year":"2006","journal-title":"Structure"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood-2006-05-023341","article-title":"EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling.","volume":"108","author":"O Salvucci","year":"2006","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1242\/jcs.061903","article-title":"Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding.","volume":"123","author":"ML Bochenek","year":"2010","journal-title":"J Cell Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1074\/mcp.T400003-MCP200","article-title":"Trypsin cleaves exclusively C-terminal to arginine and lysine residues.","volume":"3","author":"JV Olsen","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00063030-200822010-00002","article-title":"Fc-based cytokines : prospects for engineering superior therapeutics.","volume":"22","author":"JA Jazayeri","year":"2008","journal-title":"BioDrugs"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.coph.2008.06.002","article-title":"Discovering and improving novel peptide therapeutics.","volume":"8","author":"DP McGregor","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1110\/ps.19901","article-title":"Reduced antibody response to streptavidin through site-directed mutagenesis.","volume":"10","author":"DL Meyer","year":"2001","journal-title":"Protein Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/bc0155061","article-title":"Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo.","volume":"12","author":"HJ Lee","year":"2001","journal-title":"Bioconjug Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00726-005-0289-3","article-title":"Strategies to improve plasma half life time of peptide and protein drugs.","volume":"30","author":"M Werle","year":"2006","journal-title":"Amino Acids"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.RES.71.1.40","article-title":"Role of epicardial mesothelial cells in the modification of phenotype and function of adult rat ventricular myocytes in primary coculture.","volume":"71","author":"H Eid","year":"1992","journal-title":"Circ Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.RES.0000060484.11032.0B","article-title":"Epicardial\/Mesothelial cell line retains vasculogenic potential of embryonic epicardium.","volume":"92","author":"AM Wada","year":"2003","journal-title":"Circ Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/BC20100146","article-title":"Characterization of a novel angiogenic model based on stable, fluorescently labeled endothelial cell lines and suitable for high content screening.","volume":"103","author":"NL Prigozhina","year":"2011","journal-title":"Biol Cell"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1359-6446(04)03104-6","article-title":"Phage display-derived peptides as therapeutic alternatives to antibodies.","volume":"9","author":"RC Ladner","year":"2004","journal-title":"Drug Discov Today"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1359-6446(03)02623-0","article-title":"Peptide and protein drug delivery to and into tumors: challenges and solutions.","volume":"8","author":"VP Torchilin","year":"2003","journal-title":"Drug Discov Today"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1016\/j.biomaterials.2011.04.070","article-title":"Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts.","volume":"32","author":"R Zhang","year":"2011","journal-title":"Biomaterials"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1515\/znc-2003-7-819","article-title":"Increased resistance of peptides to serum proteases by modification of their amino groups.","volume":"58","author":"R Galati","year":"2003","journal-title":"Z Naturforsch C"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ccr.2004.09.030","article-title":"Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2.","volume":"6","author":"J Oliner","year":"2004","journal-title":"Cancer Cell"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals.","volume":"2","author":"JM Harris","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/biot.200900218","article-title":"PEGylation of therapeutic proteins.","volume":"5","author":"S Jevsevar","year":"2010","journal-title":"Biotechnol J"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery.","volume":"10","author":"FM Veronese","year":"2005","journal-title":"Drug Discov Today"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.addr.2009.02.010","article-title":"PEG conjugates in clinical development or use as anticancer agents: an overview.","volume":"61","author":"G Pasut","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1039\/b920570p","article-title":"PEGylated polymers for medicine: from conjugation to self-assembled systems.","volume":"46","author":"MJ Joralemon","year":"2010","journal-title":"Chem Commun (Camb)"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00063030-200822050-00004","article-title":"The impact of PEGylation on biological therapies.","volume":"22","author":"FM Veronese","year":"2008","journal-title":"BioDrugs"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/14728210902907847","article-title":"Emerging PEGylated drugs.","volume":"14","author":"JS Kang","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1038\/sj.onc.1204004","article-title":"The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.","volume":"19","author":"K Ogawa","year":"2000","journal-title":"Oncogene"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0002-9440(10)64920-6","article-title":"Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors.","volume":"160","author":"S Morikawa","year":"2002","journal-title":"Am J Pathol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1242\/dev.002071","article-title":"FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages.","volume":"135","author":"U Tigges","year":"2008","journal-title":"Development"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1387\/ijdb.103167dr","article-title":"The role of pericytes in angiogenesis.","volume":"55","author":"D Ribatti","year":"2011","journal-title":"Int J Dev Biol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1172\/JCI5028","article-title":"Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.","volume":"103","author":"LE Benjamin","year":"1999","journal-title":"J Clin Invest"},{"key":"ref64","first-page":"5012","article-title":"In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice.","volume":"59","author":"R Abramovitch","year":"1999","journal-title":"Cancer Res"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1158\/1541-7786.36.2.1","article-title":"Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis.","volume":"2","author":"J Huang","year":"2004","journal-title":"Mol Cancer Res"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.","volume":"307","author":"RK Jain","year":"2005","journal-title":"Science"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/BJ20090014","article-title":"Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.","volume":"422","author":"NK Noren","year":"2009","journal-title":"Biochem J"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1021\/bi1006223","article-title":"Structure-activity relationship analysis of peptides targeting the EphA2 receptor.","volume":"49","author":"S Mitra","year":"2010","journal-title":"Biochemistry"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/dbio.2000.0109","article-title":"Ephrin-A6, a new ligand for EphA receptors in the developing visual system.","volume":"230","author":"P Menzel","year":"2001","journal-title":"Developmental Biology"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(01)00191-X","article-title":"The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration.","volume":"104","author":"RH Adams","year":"2001","journal-title":"Cell"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0076-6879(00)27264-9","article-title":"Alkaline phosphatase fusions of ligands or receptors as in situ probes for staining of cells, tissues, and embryos.","volume":"327","author":"JG Flanagan","year":"2000","journal-title":"Methods in Enzymology"},{"issue":"Pt 19","key":"ref72","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1242\/jcs.112.19.3249","article-title":"Tensional forces in fibrillar extracellular matrices control directional capillary sprouting.","volume":"112","author":"T Korff","year":"1999","journal-title":"J Cell Sci"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0028611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T21:01:38Z","timestamp":1686517298000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0028611"}},"subtitle":[],"editor":[{"given":"Maxim","family":"Antopolsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,14]]},"references-count":72,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0028611","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,14]]}}}